A: The regulatory landscape is becoming significantly more complex, especially as lab test results make up about 80% of the data in regulatory filings. Global shifts like IVDR in Europe and evolving LDT policies in the US have introduced new challenges around compliance, timing, and operational planning. Where sponsors once worked with a single lab, they may now need several to meet country-specific requirements. These changes require deeper collaboration and earlier strategic planning. My focus is on translating new regulations into scalable, compliant processes that support our partners to keep pace with the industry's evolving needs.

A: I stay current by reading daily articles, industry emails, and attending conferences. For deeper insights, I really enjoy long-form podcasts, where discussions dive into topics in a more meaningful way. Beyond that, I actively connect with colleagues across the industry—not just within our organization—to align on trends, challenges, and best practices. The clinical research field is highly collaborative, which is something I've valued throughout my career. At the end of the day, it's all about working together to improve healthcare. If we keep that mission in focus, everything else tends to fall into place. It’s very much a team effort—collaborate together, and hopefully, win together.

A: It’s that final step—proving the safety and effectiveness of therapies and then making them widely accessible. Seeing science translate into real-world benefits for patients is incredibly fulfilling.

A: My wife and I have been married for over 25 years and blessed with 6 kids, including 2 sets of twins.